Data spanning the past 90 days through February 19, 2026 reveals that Contineum Therapeutics's three principal insider shareholders consist of Chief Scientific Officer Daniel S. Lorrain (156.05K shares), TenPercentOwner Venture Capital Vi, L.P. Versant (148.31K shares), Ceo And President Carmine N. Stengone (14.95K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Daniel S. Lorrain | Chief Scientific Officer | 156,052 | 13 Feb, 2026 |
| Venture Capital Vi, L.P. Versant | 148,312 | 11 Apr, 2024 | |
| Carmine N. Stengone | Ceo And President | 14,954 | 13 Feb, 2026 |
| Stephen L. Huhn | Cmo & Sr Vp And Clinical Dev. | 12,800 | 14 Aug, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Feb, 2026 | Carmine N. Stengone | Class A Common Stock | A | 400 | $1.26 | 15,354 | D | M |
| 11 Feb, 2026 | Carmine N. Stengone | Class A Common Stock | D | 400 | $16.00 | 14,954 | D | S |
| 11 Feb, 2026 | Daniel S. Lorrain | Class A Common Stock | A | 400 | $1.01 | 156,452 | D | M |
| 11 Feb, 2026 | Daniel S. Lorrain | Class A Common Stock | D | 400 | $16.00 | 156,052 | D | S |
| 03 Feb, 2026 | Daniel S. Lorrain | Class A Common Stock | D | 1,170 | $15.25 | 156,052 | D | S |
| 03 Feb, 2026 | Daniel S. Lorrain | Class A Common Stock | D | 3,000 | $14.82 | 157,222 | D | S |
| 28 Jan, 2026 | Tim Watkins | Class A Common Stock | D | 811 | $14.48 | 0 | D | S |
| 28 Jan, 2026 | Tim Watkins | Class A Common Stock | A | 3,611 | $4.50 | 3,611 | D | M |
| 28 Jan, 2026 | Tim Watkins | Class A Common Stock | D | 2,800 | $14.09 | 811 | D | S |
| 05 Jan, 2026 | Daniel S. Lorrain | Class A Common Stock | D | 3,670 | $10.35 | 160,722 | D | S |
| 05 Jan, 2026 | Daniel S. Lorrain | Class A Common Stock | D | 500 | $11.13 | 160,222 | D | S |
| 29 Dec, 2025 | Tim Watkins | Class A Common Stock | A | 3,611 | $4.50 | 3,611 | D | M |
| 29 Dec, 2025 | Tim Watkins | Class A Common Stock | D | 3,611 | $12.06 | 0 | D | S |
| 23 Dec, 2025 | Daniel S. Lorrain | Class A Common Stock | D | 4,170 | $12.23 | 164,392 | D | S |
| 25 Nov, 2024 | Daniel S. Lorrain | Class A Common Stock | D | 1,010 | $16.02 | 168,562 | D | S |
| 18 Nov, 2024 | Daniel S. Lorrain | Class A Common Stock | D | 99 | $17.05 | 169,572 | D | S |
| 18 Nov, 2024 | Daniel S. Lorrain | Class A Common Stock | D | 6,091 | $16.37 | 169,671 | D | S |
| 13 Aug, 2024 | Stephen L. Huhn | Class A Common Stock | A | 12,800 | $1.01 | 12,800 | D | M |
| 13 Aug, 2024 | Stephen L. Huhn | - | - | 12,800 | D | |||
| 09 Apr, 2024 | Venture Capital Vi, L.P. Versant | - | - | 391,785 | I |